Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GlaxoSmithKline Pharmaceuticals Ltd.

http://www.gsk-india.com

Latest From GlaxoSmithKline Pharmaceuticals Ltd.

Clinical Trials: Have We Finally Reached The New Normal?

Pent-up trial demand during 2020 plus trial modernization strategies yields bumper performance in 2021 as research priorities revert to pre-pandemic trends.

Clinical Trials Outlook 2023

Biogen Lures Viehbacher Back From Venture Capital As CEO

Christopher Viehbacher, former Sanofi CEO and current managing partner at Gurnet Capital, will be charged with returning Biogen to growth with a second big Alzheimer’s launch looming.

Leadership Business Strategies

EU Fast Track Sought For Epidermolysis Bullosa Gene Therapy & Bispecific RRMM Drug

Janssen and Krystal Biotech will soon learn whether the European Medicines Agency considers their respective products to be of potential major public health interest, particularly from the point of view of therapeutic innovation.

Europe Drug Review

Show Me CIIE: Can Foreign Pharma Continue Growth Trajectory In Closing China?

The largest show for multinational pharma firms in China shows new approaches to localization may be needed as the country navigates choppy waters.

China Companies
See All

Company Information

UsernamePublicRestriction

Register